The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of EGFR and HER-2 exon 20 mutations with distinct patterns of response to immune checkpoint blockade in non-small cell lung cancer.
 
Marcelo Vailati Negrao
No Relationships to Disclose
 
Alexandre Reuben
No Relationships to Disclose
 
Jacqulyne Ponville Robichaux
Patents, Royalties, Other Intellectual Property - Spectrum Pharmaceuticals; Spectrum Pharmaceuticals (Inst)
 
Xiuning Le
No Relationships to Disclose
 
Monique B. Nilsson
No Relationships to Disclose
 
Chang-jiun Wu
No Relationships to Disclose
 
Jianhua Zhang
No Relationships to Disclose
 
Lara C.A. Landry
No Relationships to Disclose
 
Emily Roarty
No Relationships to Disclose
 
Waree Rinsurongkawong
No Relationships to Disclose
 
Stephen Swisher
No Relationships to Disclose
 
George R. Simon
Honoraria - AstraZeneca; Celgene
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim; Celgene; Genentech/Roche; Lilly; Merck Serono
Speakers' Bureau - AstraZeneca; Celgene
Research Funding - Merck Sharp & Dohme
Travel, Accommodations, Expenses - ARIAD; Celgene; Genentech/Roche; Lilly; Merck Serono
 
Andrew Futreal
No Relationships to Disclose
 
Bonnie S. Glisson
Research Funding - Abbvie/Stemcentrx (Inst); Bristol-Myers Squibb (Inst); ISA Pharmaceuticals (Inst); Medimmune (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Abbvie/Stemcentrx; ISA Pharmaceuticals
 
Jianjun Zhang
Honoraria - Roche; Sino-USA Biomedical Platform
Consulting or Advisory Role - AstraZeneca
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)